Literature DB >> 18408977

Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: influence of attenuation correction method and examination interval.

Tomohito Kamibayashi1, Tatsuro Tsuchida, Yoshiki Demura, Tetsuya Tsujikawa, Hidehiko Okazawa, Takashi Kudoh, Hirohiko Kimura.   

Abstract

PURPOSE: The aim of this study is to evaluate the reproducibility of semi-quantitative parameters obtained from two 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) studies using two different PET scanners.
METHODS: Forty-five patients underwent FDG-PET examination with two different PET scanners on separate days. Two PET images with different attenuation correction method were generated in each patient, and three regions of interest (ROIs) were placed on the lung tumor and normal organs (mediastinum and liver) in each image. Mean and maximum standardized uptake values (SUVs), tumor-to-mediastinum and tumor-to-liver ratios (T/M and T/L), and the percentage difference in parameters between two PET images (% Diff.) were compared.
RESULTS: All measured values except maximum SUV in the liver and tumor-related parameters (SUV in lung tumor, T/M, T/L) showed no significant difference between two PET images.
CONCLUSION: The mean measured values showed high reproducibility and demonstrate that follow-up study or measurement of tumor response to anticancer drugs can be undertaken by FDG-PET examination without specifying the particular type of PET scanner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408977     DOI: 10.1007/s11307-008-0132-9

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  23 in total

Review 1.  Oncological applications of FDG PET imaging.

Authors:  D Delbeke
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

2.  Anatomy of SUV. Standardized uptake value.

Authors:  S C Huang
Journal:  Nucl Med Biol       Date:  2000-10       Impact factor: 2.408

3.  Combined PET/CT Imaging in Oncology. Impact on Patient Management.

Authors:  P G. Kluetz; C C. Meltzer; V L. Villemagne; P E. Kinahan; S Chander; M A. Martinelli; D W. Townsend
Journal:  Clin Positron Imaging       Date:  2000-11

4.  Can the standardized uptake value characterize primary brain tumors on FDG-PET?

Authors:  R Hustinx; R J Smith; F Benard; A Bhatnagar; A Alavi
Journal:  Eur J Nucl Med       Date:  1999-11

5.  Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Authors:  W A Weber; S I Ziegler; R Thödtmann; A R Hanauske; M Schwaiger
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

6.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

7.  Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET.

Authors:  M Souvatzoglou; S I Ziegler; M J Martinez; R Busch; G Dzewas; M Schwaiger; F Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-05       Impact factor: 9.236

8.  "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity.

Authors:  R L Wahl; L E Quint; R D Cieslak; A M Aisen; R A Koeppe; C R Meyer
Journal:  J Nucl Med       Date:  1993-07       Impact factor: 10.057

9.  PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.

Authors:  Yuji Nakamoto; Medhat Osman; Christian Cohade; Laura T Marshall; Jonathan M Links; Steve Kohlmyer; Richard L Wahl
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

10.  Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.

Authors:  H Minn; K R Zasadny; L E Quint; R L Wahl
Journal:  Radiology       Date:  1995-07       Impact factor: 11.105

View more
  14 in total

1.  Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.

Authors:  R K Doot; J S Scheuermann; P E Christian; J S Karp; P E Kinahan
Journal:  Med Phys       Date:  2010-11       Impact factor: 4.071

2.  Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.

Authors:  Wolfgang A Weber; Constantine A Gatsonis; P David Mozley; Lucy G Hanna; Anthony F Shields; Denise R Aberle; Ramaswamy Govindan; Drew A Torigian; Joel S Karp; Jian Q Michael Yu; Rathan M Subramaniam; Robert A Halvorsen; Barry A Siegel
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

3.  Noise considerations for PET quantification using maximum and peak standardized uptake value.

Authors:  Martin A Lodge; Muhammad A Chaudhry; Richard L Wahl
Journal:  J Nucl Med       Date:  2012-05-24       Impact factor: 10.057

4.  Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

Authors:  Jihyun Park; Kyoung Jin Chang; Young Seok Seo; Byung Hyun Byun; Joon Ho Choi; Hansol Moon; Ilhan Lim; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2014-08-01

5.  Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index.

Authors:  Satoshi Shiono; Naoki Yanagawa; Masami Abiko; Toru Sato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-16       Impact factor: 1.520

6.  The QIBA Profile for FDG PET/CT: Improving the Value of PET.

Authors:  Gary A Ulaner
Journal:  Radiology       Date:  2020-01-07       Impact factor: 11.105

7.  A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.

Authors:  Robert L Harrison; Brian F Elston; Robert K Doot; Thomas K Lewellen; David A Mankoff; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

Review 8.  Quantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons.

Authors:  Nancy A Obuchowski; Anthony P Reeves; Erich P Huang; Xiao-Feng Wang; Andrew J Buckler; Hyun J Grace Kim; Huiman X Barnhart; Edward F Jackson; Maryellen L Giger; Gene Pennello; Alicia Y Toledano; Jayashree Kalpathy-Cramer; Tatiyana V Apanasovich; Paul E Kinahan; Kyle J Myers; Dmitry B Goldgof; Daniel P Barboriak; Robert J Gillies; Lawrence H Schwartz; Daniel C Sullivan
Journal:  Stat Methods Med Res       Date:  2014-06-11       Impact factor: 3.021

9.  Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis.

Authors:  Oluwaseun A Odewole; Oyeladun A Oyenuga; Funmilayo Tade; Bital Savir-Baruch; Peter T Nieh; Viraj Master; Zhengjia Chen; Xiaojing Wang; Ashesh B Jani; Leah M Bellamy; Raghuveer K Halkar; Mark M Goodman; David M Schuster
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

10.  The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy.

Authors:  Paul E Kinahan; Eric S Perlman; John J Sunderland; Rathan Subramaniam; Scott D Wollenweber; Timothy G Turkington; Martin A Lodge; Ronald Boellaard; Nancy A Obuchowski; Richard L Wahl
Journal:  Radiology       Date:  2020-01-07       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.